APA (7th ed.) Citation

P, C., C, A., G, A., A, M., D, G., V, M., . . . M, C. (2023). Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3), e426. https://doi.org/10.1093/cid/ciac404

Chicago Style (17th ed.) Citation

P, Corradini, et al. "Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76, no. 3 (2023): e426. https://doi.org/10.1093/cid/ciac404.

MLA (9th ed.) Citation

P, Corradini, et al. "Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 3, 2023, p. e426, https://doi.org/10.1093/cid/ciac404.